Ands.Ns
Business description not yet wired for this issuer.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
# ANDS.NS: Business Summary
ANDS.NS operates in the Commodity Chemicals industry, producing and selling chemical products for industrial and consumer applications.
# ANDS.NS: Classification Summary
ANDS.NS is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with a confidence level of 0.92.
# ANDS.NS: Narrative
ANDS.NS maintains a strong liquidity position with a current ratio of 4.02, indicating the company can cover its short-term obligations more than four times over. However, the company reported negative free cash flow of -25.86 million INR, driven by capital expenditures of -957.13 million INR, which suggests significant reinvestment in operations. The debt-to-equity ratio of 0.01 indicates a conservative capital structure with minimal leverage.
Profitability metrics for ANDS.NS are modest, with a return on equity of 1.63% and a return on assets of 1.23%. These figures are below the industry median for Commodity Chemicals, which typically sees ROE and ROA in the 3-5% range. The company's operating income of 22.51 million INR is a small fraction of its gross profit of 8.32 billion INR, indicating high operating expenses relative to production costs.
Geographically, ANDS.NS is concentrated in a single market, with no disclosed international revenue segments. This lack of diversification increases exposure to local economic and regulatory shifts. The company's revenue of 20.20 billion INR is derived from a single business segment, which may limit growth opportunities in the event of sector-specific downturns.
Looking ahead, ANDS.NS is expected to maintain stable revenue with no significant growth or contraction projected for the current or next fiscal year. The company's capital expenditures are expected to remain high, which may continue to pressure free cash flow. The company's risk assessment indicates medium liquidity risk due to negative free cash flow and low dilution risk, with no near-term pressure from equity issuance.
Recent filings and transcripts show no material changes in the company's strategic direction or financial outlook. The company has not disclosed any new product launches or major capital projects in the latest 10-K or earnings call transcripts. The absence of recent strategic announcements suggests a focus on operational efficiency and cost control.
# ANDS.NS: Key Takeaways
- ANDS.NS has a strong liquidity position with a current ratio of 4.02 but reports negative free cash flow due to high capital expenditures. - The company's profitability metrics (ROE and ROA) are below industry medians, indicating room for improvement in operational efficiency. - Revenue and business segment concentration pose growth and diversification risks. - No near-term dilution pressure is expected, and the company maintains a conservative capital structure with minimal leverage.
# ANDS.NS: Rationales
# ANDS.NS: Inversion (DS-6)
# ANDS.NS: Self Scoring (§A.8)
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- ANDS.NS Market data — financials · 2026-05-27